Morgan Stanley Maintains Overweight on Northrop Grumman, Lowers Price Target to $745

Benzinga Newsdesk www.benzinga.com Negative 92.3%

Neg 92.3% Neu 0% Pos 0%

Morgan Stanley analyst Kristine Liwag maintains Northrop Grumman (NYSE:NOC) with a Overweight and lowers the price target from $765 to $745.